S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Tekmira Provides Corporate Update and Announces Third Quarter 2014 Results|
|Tekmira Pharmaceuticals Announces Leadership Changes|
|Tekmira to buy OnCore, creating Hepatitis B-focused 'powerhouse' (2015/1/12)|
|Tekmira Initiates Phase I Clinical Trial of TKM-HBV|
|Tekmira Provides Periodic Update on TKM-Ebola Program|
|Tekmira Receives Clearance to Conduct a Phase I Clinical Study With TKM-HBV|
|Tekmira Provides Update on TKM-PLK1 Phase I/II Clinical Study in Patients With Advanced Gastrointestinal Neuroendocrine Tumors and Adrenocortical Carcinoma|
|Tekmira Establishes Manufacturing and Clinical Trial Agreement to Provide TKM-Ebola-Guinea for Clinical Studies in West Africa|
|Tekmira Pharmaceuticals and OnCore Biopharma Announce Merger Agreement to Create Leading Global Hepatitis B Virus Company (2015/1/11)|
|Tekmira Presents Results of Preclinical Studies With Hepatitis B Therapeutic|
Click above to view more mutual fund data and stats for tkm - Tekmira Pharmaceuticals Corp.